Esophageal Diseases  >>  remifentanil  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
remifentanil / Generic mfg.
NCT01191645: Opioid Effects on Swallowing and Esophageal Sphincter Pressure

Completed
4
14
Europe
naloxone, Naloxon, ACT-code: V03AB15, remifentanil, Ultiva, ATC-code: N01AH06, Sodium Chloride, Natriumklorid, ACT-code: B05XA03, metoclopramide, Primperan
Region Örebro County
Opioid Induced Pharyngeal and Esophageal Dysfunction
11/10
11/10
NCT01495377: Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration

Completed
4
25
Europe
Remifentanil, Ultiva, ATC-code: N01AH06, Placebo, Saline, ACT-code: B05XA03, Technetium, Nanocol, ACT-code: V09DB01, Dynamometer (Jamar), Jamar dynamometer
Region Örebro County
Opioid Induced Swallowing Disorders
05/12
05/12

Download Options